Ipsen: licensing agreement and two new programs with Université de Montréal and IRICoR

(Boursier.com) — Ipsen Université de Montréal and IRICoR extend their partnership in oncology with the signing of an exclusive licensing agreement and two new programs in the research phase.

Ipsen will now manage all development and commercialization activities for the licensed asset Ipsen, Université de Montréal and IRICoR will continue their partnership with a new collaboration and an option to license two new oncology programs in the research phase.